These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24847757)

  • 1. Atrial fibrillation following intravenous zolendronic acid for osteoporosis.
    Konsta M; Bournia VK; Dania V; Iliopoulos A
    J Clin Rheumatol; 2014 Jun; 20(4):239-40. PubMed ID: 24847757
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atrial fibrillation during bisphosphonate therapy. side effects or coincidental finding?].
    Ringe JD
    MMW Fortschr Med; 2009 Mar; 151(10):7. PubMed ID: 19472655
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis and bisphosphonates].
    Zuber MA
    Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
    [No Abstract]   [Full Text] [Related]  

  • 4. Yearly zoledronic acid in postmenopausal osteoporosis.
    Poole KE; Kaptoge S; Reeve J
    N Engl J Med; 2007 Aug; 357(7):711-2; author reply 714-5. PubMed ID: 17703530
    [No Abstract]   [Full Text] [Related]  

  • 5. Yearly zoledronic acid in postmenopausal osteoporosis.
    de Nijs RN; Westgeest AA
    N Engl J Med; 2007 Aug; 357(7):711; author reply 714-5. PubMed ID: 17699824
    [No Abstract]   [Full Text] [Related]  

  • 6. A once-yearly IV bisphosphonate for osteoporosis.
    Obstet Gynecol; 2008 May; 111(5):1208-9. PubMed ID: 18448761
    [No Abstract]   [Full Text] [Related]  

  • 7. Yearly zoledronic acid in postmenopausal osteoporosis.
    Karam R; Camm J; McClung M
    N Engl J Med; 2007 Aug; 357(7):712-3; author reply 714-5. PubMed ID: 17703529
    [No Abstract]   [Full Text] [Related]  

  • 8. Consultation corner. Bone loss drug gives users a break.
    Bellantoni M
    Johns Hopkins Med Lett Health After 50; 2007 Dec; 19(10):6. PubMed ID: 18225340
    [No Abstract]   [Full Text] [Related]  

  • 9. Boning up on osteoporosis medications.
    Johns Hopkins Med Lett Health After 50; 2010 May; 22(3):1-2, 7. PubMed ID: 20518136
    [No Abstract]   [Full Text] [Related]  

  • 10. To treat osteoporosis, Denosumab appears more effective than Zoledronate. Denosumab has the advantage in building bone density, and has fewer side effects.
    Duke Med Health News; 2014 Mar; 20(3):1-2. PubMed ID: 24683617
    [No Abstract]   [Full Text] [Related]  

  • 11. Giant cell arteritis with visual loss following zoledronic acid infusion.
    Metyas S; Ibrahim M; Solyman J; Yeter KC; Arkfeld DG
    Int J Rheum Dis; 2014 Jan; 17(1):113-5. PubMed ID: 24472274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By the way, doctor. Should I take an intravenous drug for osteoporosis?
    Robb-Nicholson C
    Harv Womens Health Watch; 2007 Jul; 14(11):8. PubMed ID: 17665505
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral bisphosphonates and atrial fibrillation.
    Majumdar SR
    BMJ; 2008 Apr; 336(7648):784-5. PubMed ID: 18334526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New annual osteoporosis drug reduces risk of death, future fractures. Infused dose is more convenient for patients, enhances overall quality of life.
    Duke Med Health News; 2007 Dec; 13(12):8. PubMed ID: 18286732
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis drugs not linked to atrial fibrillation.
    Harv Heart Lett; 2009 Apr; 19(8):6. PubMed ID: 19685565
    [No Abstract]   [Full Text] [Related]  

  • 16. Avascular necrosis of the proximal carpal row of the wrist. A possible complication of bisphosphonate administration.
    Didden K; De Smet L; Vandenberghe L; Sciot R; Degreef I
    Chir Main; 2012 Dec; 31(6):355-7. PubMed ID: 23177907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New bone density conservation agents for osteoporosis under research and development: Zoledronate].
    Wada S; Fukawa T; Kamiya S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():421-5. PubMed ID: 18161143
    [No Abstract]   [Full Text] [Related]  

  • 18. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 19. Zoledronic acid and osteonecrosis of the jaw: incidence varies with use.
    Wynn RL
    Gen Dent; 2011; 59(5):330-2. PubMed ID: 22313815
    [No Abstract]   [Full Text] [Related]  

  • 20. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.